moclobemide has been researched along with MS (Multiple Sclerosis) in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No adverse effects were noted." | 6.69 | Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial. ( Achiron, A; Barak, Y; Ur, E, 1999) |
| " No adverse effects were noted." | 2.69 | Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial. ( Achiron, A; Barak, Y; Ur, E, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holsboer, F | 1 |
| Grasser, A | 1 |
| Friess, E | 1 |
| Wiedemann, K | 1 |
| Barak, Y | 1 |
| Ur, E | 1 |
| Achiron, A | 1 |
1 review available for moclobemide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Steroid effects on central neurons and implications for psychiatric and neurological disorders.
Topics: Adrenocorticotropic Hormone; Amitriptyline; Benzamides; Brain; Corticotropin-Releasing Hormone; Dexa | 1994 |
1 trial available for moclobemide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial.
Topics: Adult; Depressive Disorder; Female; Humans; Male; Middle Aged; Moclobemide; Multiple Sclerosis; Pilo | 1999 |